Firm Newsletter, Spring 2008

May 1, 2008

By: Martha S. Helmreich , Michael A. Morse , Kevin E. Raphael , Paul Kenneth Vey

Articles In This Issue:

1. Criminal and Civil Liability to Physicians and Other Health Care Providers For the Off-Label Marketing of FDA-Approved Drugs or Devices: An Emerging Trend?
2. Mandatory Rules For Pennsylvania Medical Facilities For Reporting Medical Errors, Adverse Events And Device Failures
3. Hospital mergers Receive Closer Antitrust  Scrutiny From Federal Trade Commission
4. M-Care Iinfection Control: A Litigation Threat?
5. UPDATE: Federal Pre-emption Of State Tort Claims Involving Medical Devices And Pharmaceutical Products

Related Information:

News & Events

Related News

20 Pietragallo Lawyers Named in 2022 The Best Lawyers in America and Ones to Watch
August 19, 2021
Pietragallo Gordon Alfano Bosick & Raspanti, LLP is pleased to announce that 20 lawyers have been named as 2022 The Best Lawyers in America and 2022 Ones to Watch, including two lawyers who were recognized for Bet-the-Company Litigation. Read More
Alliance Family of Companies and Ancor Capital Partners Pay $15.3M to Settle False Claims Suits
July 22, 2021
The Department of Justice and the United States Attorney’s Office for the Southern District of Texas, has announced the settlement of six qui tam cases filed in Houston, Dallas, and Philadelphia.  Read More
View More News & Events